|
1
|
Wyllie AH, Kerr JF and Currie AR: Cell
death: The significance of apoptosis. Int Rev Cytol. 68:251–306.
1980. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang J, Chan JY, Fong CC, Tzang CH, Fung
KP and Yang M: Transcriptional analysis of doxorubicin-induced
cytotoxicity and resistance in human hepatocellular carcinoma cell
lines. Liver Int. 29:1338–1347. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sen S and D’Incalci M: Apoptosis.
Biochemical events and relevance to cancer chemotherapy. FEBS Lett.
307:122–127. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Colombel M, Olsson CA, Ng PY and Buttyan
R: Hormone-regulated apoptosis results from reentry of
differentiated prostate cells onto a defective cell cycle. Cancer
Res. 52:4313–4319. 1992.PubMed/NCBI
|
|
5
|
Ucker DS: Death by suicide: One way to go
in mammalian cellular development? New Biol. 3:103–109.
1991.PubMed/NCBI
|
|
6
|
Katayama H, Wang J, Treekitkarnmongkol W,
Kawai H, Sasai K, Zhang H, Wang H, Adams HP, Jiang S, Chakraborty
SN, et al: Aurora kinase-A inactivates DNA damage-induced apoptosis
and spindle assembly checkpoint response functions of p73. Cancer
Cell. 21:196–211. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Elledge SJ and Spottswood MR: A new human
p34 protein kinase, CDK2, identified by complementation of a cdc28
mutation in Saccharomyces cerevisiae, is a homolog of Xenopus Eg1.
EMBO J. 10:2653–2659. 1991.PubMed/NCBI
|
|
8
|
Zhu J, Sen S, Wei C and Frazier ML: Cyclin
D1b represses breast cancer cell growth by antagonizing the action
of cyclin D1a on estrogen receptor α-mediated transcription. Int J
Oncol. 36:39–48. 2010.
|
|
9
|
Nurse P: Ordering S phase and M phase in
the cell cycle. Cell. 79:547–550. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
King RW, Jackson PK and Kirschner MW:
Mitosis in transition. Cell. 79:563–571. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sherr CJ: G1 phase progression: Cycling on
cue. Cell. 79:551–555. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Morgan DO: Principles of CDK regulation.
Nature. 374:131–134. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Forsburg SL and Nurse P: Cell cycle
regulation in the yeasts Saccharomyces cerevisiae and
Schizosaccharomyces pombe. Annu Rev Cell Biol. 7:227–256. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
DeGregori J, Leone G, Ohtani K, Miron A
and Nevins JR: E2F-1 accumulation bypasses a G1 arrest resulting
from the inhibition of G1 cyclin-dependent kinase activity. Genes
Dev. 9:2873–2887. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ikeda MA, Jakoi L and Nevins JR: A unique
role for the Rb protein in controlling E2F accumulation during cell
growth and differentiation. Proc Natl Acad Sci USA. 93:3215–3220.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Krek W, Xu G and Livingston DM: Cyclin
A-kinase regulation of E2F-1 DNA binding function underlies
suppression of an S phase checkpoint. Cell. 83:1149–1158. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang Y, Ishiko T, Nakada S, Utsugisawa T,
Kato T and Yuan ZM: Role for E2F in DNA damage-induced entry of
cells into S phase. Cancer Res. 57:3640–3643. 1997.PubMed/NCBI
|
|
18
|
Li WW, Fan J, Hochhauser D and Bertino JR:
Overexpression of p21waf1 leads to increased inhibition of E2F-1
phosphorylation and sensitivity to anticancer drugs in
retinoblastoma-negative human sarcoma cells. Cancer Res.
57:2193–2199. 1997.PubMed/NCBI
|
|
19
|
Price J, Fabra A, Zhang R, Radinsky R and
Pathak S: Characterization of variants of a human breast-cancer
cell-line isolated from metastases in different organs of
nude-mice. Int J Oncol. 5:459–467. 1994.PubMed/NCBI
|
|
20
|
Graña X and Reddy EP: Cell cycle control
in mammalian cells: Role of cyclins, cyclin dependent kinases
(CDKs), growth suppressor genes and cyclin-dependent kinase
inhibitors (CKIs). Oncogene. 11:211–219. 1995.PubMed/NCBI
|
|
21
|
Elledge SJ, Richman R, Hall FL, Williams
RT, Lodgson N and Harper JW: CDK2 encodes a 33-kDa cyclin
A-associated protein kinase and is expressed before CDC2 in the
cell cycle. Proc Natl Acad Sci USA. 89:2907–2911. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Moyer JD, Smith PA, Levy EJ and
Handschumacher RE: Kinetics of N-(phosphonacetyl)-L-aspartate and
pyrazofurin depletion of pyrimidine ribonucleotide and
deoxyribonucleotide pools and their relationship to nucleic acid
synthesis in intact and permeabilized cells. Cancer Res.
42:4525–4531. 1982.PubMed/NCBI
|
|
23
|
Grem JL, King SA, O’Dwyer PJ and
Leyland-Jones B: Biochemistry and clinical activity of
N-(phosphonacetyl)-L-aspartate: A review. Cancer Res. 48:4441–4454.
1988.PubMed/NCBI
|
|
24
|
Ruhul Amin AR, Thakur VS, Gupta K, Agarwal
MK, Wald DN, Shin DM and Agarwal ML: N-(phosphonacetyl)-L-aspartate
induces TAp73-dependent apoptosis by modulating multiple Bcl-2
proteins: Potential for cancer therapy. Oncogene. 32:920–929. 2013.
View Article : Google Scholar
|
|
25
|
Katayama H, Sasai K, Kawai H, Yuan ZM,
Bondaruk J, Suzuki F, Fujii S, Arlinghaus RB, Czerniak BA and Sen
S: Phosphorylation by aurora kinase A induces Mdm2-mediated
destabilization and inhibition of p53. Nat Genet. 36:55–62. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lotem J and Sachs L: Regulation by bcl-2,
c-myc, and p53 of susceptibility to induction of apoptosis by heat
shock and cancer chemotherapy compounds in
differentiation-competent and -defective myeloid leukemic cells.
Cell Growth Differ. 4:41–47. 1993.PubMed/NCBI
|
|
27
|
Hoang AT, Cohen KJ, Barrett JF, Bergstrom
DA and Dang CV: Participation of cyclin A in Myc-induced apoptosis.
Proc Natl Acad Sci USA. 91:6875–6879. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Takahashi T, Yamasaki F, Sudo T, Itamochi
H, Adachi S, Tamamori-Adachi M and Ueno NT: Cyclin A-associated
kinase activity is needed for paclitaxel sensitivity. Mol Cancer
Ther. 4:1039–1046. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Debbas M and White E: Wild-type p53
mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev.
7:546–554. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lowe SW, Ruley HE, Jacks T and Housman DE:
p53-dependent apoptosis modulates the cytotoxicity of anticancer
agents. Cell. 74:957–967. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Evans DL and Dive C: Effects of cisplatin
on the induction of apoptosis in proliferating hepatoma cells and
nonproliferating immature thymocytes. Cancer Res. 53:2133–2139.
1993.PubMed/NCBI
|
|
32
|
Gorczyca W, Gong J, Ardelt B, Traganos F
and Darzynkiewicz Z: The cell cycle related differences in
susceptibility of HL-60 cells to apoptosis induced by various
antitumor agents. Cancer Res. 53:3186–3192. 1993.PubMed/NCBI
|
|
33
|
Wang J, Fong CC, Tzang CH, Xiao P, Han R
and Yang M: Gene expression analysis of human promyelocytic
leukemia HL-60 cell differentiation and cytotoxicity induced by
natural and synthetic retinoids. Life Sci. 84:576–583. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ashwell JD, Cunningham RE, Noguchi PD and
Hernandez D: Cell growth cycle block of T cell hybridomas upon
activation with antigen. J Exp Med. 165:173–194. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Howard MK, Burke LC, Mailhos C, Pizzey A,
Gilbert CS, Lawson WD, Collins MK, Thomas NS and Latchman DS: Cell
cycle arrest of proliferating neuronal cells by serum deprivation
can result in either apoptosis or differentiation. J Neurochem.
60:1783–1791. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ryan JJ, Danish R, Gottlieb CA and Clarke
MF: Cell cycle analysis of p53-induced cell death in murine
erythroleukemia cells. Mol Cell Biol. 13:711–719. 1993.PubMed/NCBI
|
|
37
|
Kastan MB, Canman CE and Leonard CJ: P53,
cell cycle control and apoptosis: Implications for cancer. Cancer
Metastasis Rev. 14:3–15. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shi L, Nishioka WK, Th’ng J, Bradbury EM,
Litchfield DW and Greenberg AH: Premature p34cdc2 activation
required for apoptosis. Science. 263:1143–1145. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Meikrantz W and Schlegel R: Apoptosis and
the cell cycle. J Cell Biochem. 58:160–174. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Meikrantz W, Gisselbrecht S, Tam SW and
Schlegel R: Activation of cyclin A-dependent protein kinases during
apoptosis. Proc Natl Acad Sci USA. 91:3754–3758. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Heald R, McLoughlin M and McKeon F: Human
wee1 maintains mitotic timing by protecting the nucleus from
cytoplasmically activated Cdc2 kinase. Cell. 74:463–474. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Rudolph B, Saffrich R, Zwicker J, Henglein
B, Müller R, Ansorge W and Eilers M: Activation of cyclin-dependent
kinases by Myc mediates induction of cyclin A, but not apoptosis.
EMBO J. 15:3065–3076. 1996.PubMed/NCBI
|
|
43
|
Logan TJ, Evans DL, Mercer WE, Bjornsti MA
and Hall DJ: Expression of a deletion mutant of the E2F1
transcription factor in fibroblasts lengthens S phase and increases
sensitivity to S phase-specific toxins. Cancer Res. 55:2883–2891.
1995.PubMed/NCBI
|
|
44
|
Fotedar A, Cannella D, Fitzgerald P,
Rousselle T, Gupta S, Dorée M and Fotedar R: Role for cyclin
A-dependent kinase in DNA replication in human S phase cell
extracts. J Biol Chem. 271:31627–31637. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gandhi V, Danhauser L and Plunkett W:
Separation of 1-beta-D-arabinofuranosylcytosine 5′-triphosphate and
9-beta-D-arabinofuranosyl-2-fluoroadenine 5′-triphosphate in human
leukemia cells by high-performance liquid chromatography. J
Chromatogr A. 413:293–299. 1987. View Article : Google Scholar
|
|
46
|
Shirodkar S, Ewen M, DeCaprio JA, Morgan
J, Livingston DM and Chittenden T: The transcription factor E2F
interacts with the retinoblastoma product and a p107-cyclin A
complex in a cell cycle-regulated manner. Cell. 68:157–166. 1992.
View Article : Google Scholar : PubMed/NCBI
|
